Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-6,214
Closed -$311K 363
2025
Q4
$311K Buy
6,214
+100
+2% +$4.81K 0.17% 113
2025
Q3
$300K Hold
6,114
0.17% 115
2025
Q2
$316K Buy
6,114
+590
+11% +$27.1K 0.19% 97
2025
Q1
$258K Buy
5,524
+225
+4% +$11.6K 0.16% 123
2024
Q4
$271K Buy
5,299
+125
+2% +$6.48K 0.18% 106
2024
Q3
$230K Buy
5,174
+175
+4% +$7.65K 0.14% 154
2024
Q2
$201K Buy
4,999
+215
+4% +$8.15K 0.13% 155
2024
Q1
$192K Sell
4,784
-50
-1% -$1.88K 0.12% 170
2023
Q4
$182K Buy
+4,834
New +$148K 0.11% 158

Other funds holding SNV

Cetera Trust Company's SNV Position: Q1 2026 in Review

Cetera Trust Company sold out of Synovus (SNV) in Q1 2026, closing a stake of 6,214 shares — an estimated $311K sold.

Cetera Trust Company first reported a position in SNV in Q4 2023 and held it in 9 quarters. The position peaked at $316K in Q2 2025. 1 fund tracked by Wall St. Rank holds SNV as of Q1 2026.

  • Cetera Trust Company reported no remaining Synovus position as of Q1 2026 after selling out during the quarter.
  • Cetera Trust Company sold 6,214 Synovus shares in Q1 2026, an estimated $311K.
  • Cetera Trust Company first reported a position in Synovus in Q4 2023 and held it in 9 quarters.
  • Cetera Trust Company's Synovus position peaked at $316K in Q2 2025.
  • 1 fund tracked by Wall St. Rank held Synovus as of Q1 2026.

Based on Cetera Trust Company's 13F filing for Q1 2026, filed 8 May 2026.